Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Other Accumulated Expenses (2017 - 2019)

Macrogenics (MGNX) has disclosed Other Accumulated Expenses for 6 consecutive years, with $175000.0 as the latest value for Q3 2019.

  • On a quarterly basis, Other Accumulated Expenses changed 0.0% to $175000.0 in Q3 2019 year-over-year; TTM through Sep 2019 was $175000.0, a 0.0% change, with the full-year FY2018 number at $175000.0, down 63.0% from a year prior.
  • Other Accumulated Expenses was $175000.0 for Q3 2019 at Macrogenics, roughly flat from $175000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $1.6 million in Q1 2015 to a low of $175000.0 in Q3 2017.
  • A 4-year average of $570384.6 and a median of $175000.0 in 2017 define the central range for Other Accumulated Expenses.
  • Peak YoY movement for Other Accumulated Expenses: surged 342.25% in 2015, then crashed 63.0% in 2018.
  • Macrogenics' Other Accumulated Expenses stood at $727000.0 in 2015, then plummeted by 34.94% to $473000.0 in 2017, then plummeted by 63.0% to $175000.0 in 2018, then changed by 0.0% to $175000.0 in 2019.
  • Per Business Quant, the three most recent readings for MGNX's Other Accumulated Expenses are $175000.0 (Q3 2019), $175000.0 (Q2 2019), and $175000.0 (Q1 2019).